Felodipine
Product Images NDC 55648-412

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Felodipine (NDC 55648-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label (Felodipine Er Tablets Container Label 10 mg 500t)

Label for Felodipine Extended-Release Tablets, USP 10 mg, manufactured by Wockhardt Limited and distributed by Wockhardt USA LLC. The label includes storage instructions to keep tablets protected from light and stored at 20°-25°C. It specifies the tablets should be swallowed whole and provides usual dosage instructions to see the package insert. The package contains 500 tablets.*

FDA Label Image

Container Label (Felodipine Er Tablets Container Label 2.5 mg 100t)

Label for Felodipine Extended-Release Tablets USP 2.5 mg, containing 100 tablets. The label includes storage instructions to keep the container tightly closed and protect from light, and to store at 20°-25°C (68°-77°F). It also advises that tablets should be swallowed whole, not crushed or chewed. The product is distributed by Wockhardt LLC and manufactured by Wockhardt Limited, Mumbai, India. The label indicates the product is Rx only and displays an NDC barcode.*

FDA Label Image

Container Label (Felodipine Er Tablets Container Label 5 mg 100t)

Label for Felodipine Extended-Release Tablets, USP 5 mg, by Wockhardt Limited. The label includes storage instructions, dosage form, strength, and package size of 100 tablets. It shows the distributor and manufacturer details along with a barcode and NDC 64679-412-02.*

FDA Label Image

Structure (Felodipine Structure)

Chemical structure diagram of Felodipine, displaying its molecular configuration with functional groups and halogen substitutions. The structure illustrates the positions of methyl, methoxycarbonyl, ethoxycarbonyl, and dichlorophenyl groups attached to the dihydropyridine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.